According to Syndax Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$0.35 B. In 2023 the company made an earning of -S$0.28 B a decrease over its 2022 earnings that were of -S$0.2 B.The earnings displayed on this page is the company's Pretax Income.